FDA, CDC Issue Alert for Sanofi-Aventis' Menactra

Drug Industry Daily
KEYWORDS FDA
A A

The FDA and the Centers for Disease Control and Prevention have issued a health alert after five people who received sanofi-aventis’ meningitis vaccine Menactra developed a serious nerve disorder.

To View This Article:

Login

Subscribe To Drug Industry Daily